| Description |
1 online resource (197 p.) |
| Series |
Chapman and Hall/CRC Internet of Things Series |
|
Chapman and Hall/CRC Internet of Things Series
|
| Contents |
Cover -- Half Title -- Series Page -- Title Page -- Copyright Page -- Table of Contents -- Note on the Editor -- List of Contributors -- Chapter 1: The Brain: Its Structure and Functions -- 1.1 Introduction -- 1.2 Structure of the Brain -- 1.2.1 Forebrain -- 1.2.1.1 The Cerebrum -- 1.2.1.2 The Cortex -- 1.2.2 The Midbrain -- 1.2.2.1 The Pons -- 1.2.2.2 The Medulla -- 1.2.3 The Hindbrain -- 1.3 Brain Diseases -- 1.3.1 Types of Brain Diseases -- 1.4 Measures to Maintain Healthy Brain Functions -- 1.4.1 Diagnosis of Disease -- References |
|
Chapter 2: The Current Status of Cognitive Disorders and Their Diagnosis -- 2.1 Introduction -- 2.2 Lewy Body Dementia -- 2.2.1 Epidemiology -- 2.2.2 Pathogenesis -- 2.2.3 Clinical Symptoms -- 2.2.4 Diagnostic Standards -- 2.2.5 Challenges -- 2.3 Acute Disseminated Encephalomyelitis (ADEM) -- 2.3.1 Epidemiology -- 2.3.2 Aetiology of the Disease -- 2.3.3 Pathogenesis -- 2.3.4 Clinical Manifestation -- 2.3.5 Diagnostic Evaluation -- 2.4 Attention Deficit Hyperactivity Disorder (ADHD) -- 2.4.1 Clinical Variants of ADHD -- 2.4.2 Symptoms -- 2.4.3 Diagnosis -- 2.5 Alzheimer's Disease (AD) |
|
2.5.1 Prevalence -- 2.5.2 Pathogenesis -- 2.5.2.1 The Metabolic Pathway of Nerve Growth Factor (NGF) -- 2.5.2.2 The Signal Transducer and Activator of the Transcription Pathway: Janus Kinase -- 2.5.2.3 The FGF7/FRFR2/PI3K/AKT Pathway -- 2.5.3 Clinical Symptoms -- 2.5.3.1 Mild Alzheimer's Disease Symptoms -- 2.5.3.2 Moderate Alzheimer's Disease Symptoms -- 2.5.3.3 Warning Signs of Advanced Alzheimer's -- 2.6 Frontotemporal Dementia (FTD) -- 2.6.1 Epidemiology -- 2.6.2 Symptoms -- 2.6.2.1 FTD with Behavioural Variants -- 2.6.2.2 Primarily Progressive Non-fluent Aphasia |
|
2.6.2.3 Primary Progressive Aphasia with Semantic Variation -- 2.6.3 Diagnosis -- 2.7 Epilepsy -- 2.7.1 Epidemiology -- 2.7.2 Pathogenesis -- 2.7.3 Epilepsy's Cognitive Impairment Mechanisms -- 2.7.4 Cognitive Impairment and Epileptiform Activity -- 2.7.5 Symptoms -- 2.7.6 Diagnosis -- 2.8 Posterior Cortical Atrophy (PCA) -- 2.8.1 Clinical Features -- 2.8.2 Diagnosis -- 2.9 Parkinson's Disease (PD) -- 2.9.1 Epidemiology -- 2.9.2 Pathophysiology -- 2.9.2.1 Systemic Neurotransmitter Decline and Larger Dopaminergic Deficiencies throughout the Brain |
|
2.9.2.2 Sympathetic and Noradrenergic Nervous Systems -- 2.9.2.3 Basic Cholinergic Systems in the Forebrain -- 2.9.3 Genetic Influences -- 2.9.4 Clinical Features -- 2.9.5 Diagnosis -- 2.10 Acute Disseminated Encephalomyelitis (ADEM) -- 2.10.1 Epidemiology -- 2.10.2 Etiopathogenesis -- 2.10.3 Clinical Signs and Symptoms -- 2.10.4 Diagnostic Criteria -- References -- Chapter 3: Current Cognitive Medical Tests and Available Therapies -- 3.1 Introduction -- 3.2 Comparable Cognitive Evaluations -- 3.2.1 Mini-Mental State Examination -- 3.2.1.1 Advantages -- 3.2.1.2 Disadvantages |
| Notes |
Description based upon print version of record |
|
3.2.2 Clock-drawing Test |
| Form |
Electronic book
|
| ISBN |
9781000992915 |
|
1000992918 |
|
